Loading provider…
Loading provider…
Neurology Physician in Fargo, ND
NPI: 1235423393Primary Practice Location
SANFORD MEDICAL CENTER FARGO
801 Broadway N, Fargo, ND
Primary Employer
Sanford Medical Center - Cavalier
sanfordhealth.org
HQ Phone
Get D.O. Scott's Phone Numberphone_androidMobile
Get D.O. Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
ND State Medical License

SD State License
Active through 2027

ND State License
2020 - 2026

MN State License
2020 - 2025

MT State License
2023 - 2025

UT State License
2016 - 2022

KS State License
2015 - 2020

MO State License
2012 - 2015

American Board of Psychiatry and Neurology
Neurology
University of Kansas School of Medicine - Kansas City
kumc.edu
Residency • Neurology
2011 - 2015
Fellowship • Neuroimmunology & Multiple Sclerosis
2015 - 2017
Michigan State University College Of Osteopathic Medicine
osteopathicmedicine.msu.edu
Medical School
Until 2011
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 104 | 165 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 55 | 64 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 46 | 46 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 24 | 24 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 15 | 17 |
Reversible cerebral vasoconstriction syndrome in association with fingolimod use
Authors: Belliston, Scott, Sundararajan, Jayshree, Hammond, Nancy, Newell, Kathy, Lynch, Sharon
Journal: Int J Neurosci
Publication Date: 2016-11-23
Reversible cerebral vasoconstriction syndrome in association with fingolimod use.
Authors: Nancy Hammond
Publication Date: 2016-11-08
In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
Authors: Choi, In-Young, Lee, Phil, Adany, Peter, Hughes, Abbey J, Belliston, Scott, Denney, Douglas R, Lynch, Sharon G
Journal: Mult Scler
Publication Date: 2017-06-01
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: MRI contrast-enhancing agents, DRUG: Frexalimab
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Teriflunomide, DRUG: Activated charcoal, DRUG: Placebo tablet, DRUG: Placebo infusion, DRUG: MRI contrast-enhancing agents, DRUG: Cholestyramine, DRUG: Frexalimab